Iovance Biotherapeutics IOVA SEC Filings

NASDAQ IOVA
$8.72 +0.02 (+0.17%)
As of: Sep 4, 2026 · 3:17 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Iovance Biotherapeutics, Inc. (IOVA) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index